These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33043369)

  • 1. A Case report of atovaquone/proguanil induced esophageal ulcers.
    Carnino L; Hulo C; Puppa G; Konan DB; Chappuis F
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 33043369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of malarone in therapy of malaria tropica].
    Ziegler T; Schau A; Winkler C
    Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK; Parise ME; Lewis LS; Kain KC
    Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
    Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
    Kamaliddin C; Joste V; Argy N; Houzé S
    Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
    [No Abstract]   [Full Text] [Related]  

  • 10. Atovaquone-proguanil treatment failure in a case of pediatric Plasmodium falciparum infection: Malabsorption and resistance.
    L'Huillier AG; Lau R; Bitnun A; Boggild AK
    Travel Med Infect Dis; 2020; 37():101829. PubMed ID: 32763494
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child].
    Aurégan C; Argy N; Hubert V; Aprahamian A; Clain J; Cheron G
    Presse Med; 2017 Mar; 46(3):344-346. PubMed ID: 28040348
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
    Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
    Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme and Malarone(®).
    Becher G; Wylie G
    Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
    Contentin L; Grammatico-Guillon L; Desoubeaux G; Baron S; Thanh HD
    Presse Med; 2011 Nov; 40(11):1081-3. PubMed ID: 21570798
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil.
    Kaman A; Tanır G; Akkaya B; Bayhan Gİ; Gayretli Aydın ZG; Aydın Teke T
    Turkiye Parazitol Derg; 2018 Sep; 42(3):233-236. PubMed ID: 30072357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of Cytochrome
    Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
    Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR
    Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.